• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.19%

    Impax Laboratories Inc. (IPXL)

    -NasdaqGS
    40.47 Up 0.54(1.35%) 12:40PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:39.93
    Open:39.92
    Bid:40.52 x 100
    Ask:40.54 x 100
    1y Target Est:39.62
    Beta:1.44
    Earnings Date:Apr 29 - May 4 (Est.)
    Day's Range:39.92 - 40.86
    52wk Range:22.12 - 41.39
    Volume:261,926
    Avg Vol (3m):676,308
    Market Cap:2.79B
    P/E (ttm):49.96
    EPS (ttm):0.81
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    IPXLUp 1.35%2.79B
    MYLUp 0.58%20.89B
    TEVADown 0.00%48.10B

    Key Statistics

    Forward P/E (1 yr):19.03
    P/S (ttm):4.62
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :1.59
    Quarterly EPS Est (Mar-15) :0.15
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):1.43

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Impax Laboratories, Inc., a specialty pharmaceutical company, develops, manufactures, and markets bioequivalent pharmaceutical products. It operates in two segments, Global Pharmaceuticals Division and Impax Pharmaceuticals Division. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback